Literature DB >> 6998292

Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus.

R M Blaese, J Grayson, A D Steinberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998292     DOI: 10.1016/0002-9343(80)90003-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  43 in total

1.  Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus.

Authors:  P Airŏ; S Braga; E Prati; D Brugnoni; M Bettinzioli; R Gorla; R Cattaneo
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

2.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

3.  The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.

Authors:  M Blank; B Sredni; M Albeck; E Mozes; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 4.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

Review 5.  Control of IgE synthesis in man.

Authors:  D Y Leung; R S Geha
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

6.  Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss.

Authors:  Donna A Culton; Matilda W Nicholas; Donna O Bunch; Quan Li Zhen; Thomas B Kepler; Mary Anne Dooley; Chandra Mohan; Patrick H Nachman; Stephen H Clarke
Journal:  J Clin Immunol       Date:  2006-12-29       Impact factor: 8.317

7.  B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells.

Authors:  O Dar; M R Salaman; M H Seifert; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

8.  Pseudoplaque formation by cytophilic immunoglobulins in the sera of lupus patients as measured using reverse haemolytic plaque assay.

Authors:  M Okubo; K Kamata; T Uchiyama
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

9.  Generation of monoclonal anti-dermatan sulphate antibodies cross-reacting to calf thymus DNA.

Authors:  K Ohnishi; A Sagawa; T Nakabayashi; A Ohmoto; M Yoshikawa; I Watanabe; M Mukai; I Yasuda; S Nakagawa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

10.  Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.

Authors:  M K Hari Kumar; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.